Skip to main content
uniQure N.V. logo

uniQure N.V. — Investor Relations & Filings

Ticker · QURE ISIN · NL0010696654 LEI · 724500RPCTZLFYJZ3S98 US Manufacturing
Filings indexed 859 across all filing types
Latest filing 2023-06-22 Regulatory Filings
Country NL Netherlands
Listing US QURE

About uniQure N.V.

https://www.uniqure.com/

uniQure N.V. is a gene therapy company focused on developing and commercializing treatments for patients with rare and severe diseases. The company utilizes its adeno-associated virus (AAV) based technology platform to create single-administration therapies with the potential for curative results. Its research and development pipeline is concentrated on liver-directed and central nervous system (CNS) disorders, with a key clinical program targeting Huntington's disease. uniQure aims to deliver transformative medicines by translating scientific innovation into viable treatments.

Recent filings

Filing Released Lang Actions
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events or updates that shareholders should know about. The content includes announcements of press releases regarding a $100 million milestone and interim clinical trial data updates. It does not contain full financial statements or comprehensive financial analysis typical of Annual Reports (10-K) or Interim Reports (IR). It also does not fit categories like Earnings Release (ER) since it is more detailed and event-driven, nor is it a Management Report or Governance Information. The document is primarily a regulatory filing to disclose material events and updates, consistent with the purpose of Form 8-K filings. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length (13,397 characters) and detailed event description support this classification rather than a brief announcement or a full report.
2023-06-22 English
PRIMARY DOCUMENT
Director's Dealing
2023-06-20 English
PRIMARY DOCUMENT
Director's Dealing
2023-06-20 English
PRIMARY DOCUMENT
Director's Dealing
2023-06-20 English
PRIMARY DOCUMENT
Director's Dealing
2023-06-20 English
PRIMARY DOCUMENT
Director's Dealing
2023-06-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.